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Abstract Recently, we have reported the isolation and purifica-
tion of 20S proteasomes from both the procyclic and bloodstream 
forms of Trypanosoma brucei, but no 26S proteasome was 
identified under those experimental conditions (Una et al., Mol. 
Biochem. Parasitol. (1996) 78, 33-46). Subsequent attempts to 
identify a 26S proteasome in T. brucei led to the discovery of 
another form of the 20S proteasome designated the activated 20S 
proteasome because it exhibited much higher peptidase activities 
than the original 20S proteasome on all the fluorogenic peptides 
tested, and it crossreacted with the rabbit antisera against the 
20S proteasomes purified from T. brucei. The activated 20S 
proteasome can be isolated from both procyclic and bloodstream 
forms of T. brucei and has a slightly higher molecular weight 
than the 20S proteasome. It is stable in the absence of ATP but 
susceptible to elution through a DE52 column. Analysis of the 
activated 20S proteasome in SDS-PAGE showed the presence of 
all the subunit proteins from the 20S proteasome plus an extra 
protein with an estimated molecular mass of 26 kDa. This 
protein, designated PA26, is not a degradation product of the 
20S proteasomal subunit proteins. It could be a homolog of the 
bovine PA28 and human IIS regulator protein which form 
complexes with the 20S proteasomes resulting in activation of 
their peptidase activities. This likelihood was confirmed in a 
reconstitution experiment in which PA26 separated from the 
proteasome by a DE52 column chromatography was re-
introduced into the purified 20S proteasome, and resulted in 
the emergence of a new protein band with the same mobility and 
peptidase activities as the activated 20S proteasome in native 
polyacrylamide gel electrophoresis. The presence of an activated 
20S proteasome rather than a homolog of the 26S proteasome in 
T. brucei suggests that PA26 may play an important role in 
regulating the proteasome-mediated protein degradations in 
trypanosomes. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The ubiquitin-proteasome-mediated pathway constitutes the 
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major nonlysosomal protein degradation in the cytosol and 
nucleus of eukaryotes [1]. It plays a major role in controlling 
cell proliferation [2,3], cell cycle progression [4,5], cell differ-
entiation [6], and gene transcription [7]. Recent evidence also 
suggests an indispensable role of the ubiquitin-proteasome 
pathway in MHC class I antigen processing and presentation 
[8,9]. The 26S proteasome is an essential component of the 
highly regulated, ATP-dependent proteolysis, which catalyzes 
the rapid degradation of many proteins of important biolog-
ical functions such as ornithine decarboxylase (ODC) [10], cell 
cycle regulatory proteins (e.g. the cyclins) [4,11], transcription-
al regulators (e.g. IKB and N F - K B ) [7], as well as the abnor-
mal proteins [12], which may arise from mutation or post-
translational damage. In most cases, the ATP-dependent 
proteolytic pathway is ubiquitin-dependent. The substrates 
need to be polyubiquitinated in the presence of the ubiqui-
tin-conjugating enzymes El, E2 and E3 before being degraded 
by the 26S proteasome [1,13]. However, ubiquitin-independent 
proteolysis also exists. The best-studied example is the short-
lived enzyme ODC, which is a key enzyme in polyamine bio-
synthesis. Degradation of ODC in mammalian cells requires a 
complex formation between ODC and another protein, the 
antizyme, without involving ubiquitination [10]. 
The proteolytic core in a 26S proteasome is the multicata-
lytic protease (MCP) [14] otherwise known as the 20S protea-
some [15]. It is a barrel-shaped particle of four stacked rings 
with two oc-rings at the ends and two |3-rings in the center. 
Each ring is composed of seven subunit proteins and a feature 
which is conserved from the prokaryotes to the eukaryotes 
[16]. However, the subunit compositions are subjected to dra-
matic modifications in the course of evolution from as simple 
as two types of subunits (a and (3) in the archaebacterium 
Thermoplasma acidophilum [17] to as many as 7 different el-
and 7 different |3-subunits in higher eukaryotes [16]. The con-
struction of T. acidophilum 20S proteasome in the OC7P7P7OI7 
form was recently confirmed by X-ray crystallography [18]. 
Generally, the purified 20S proteasomes possess only low lev-
els of peptidase activity without any proteolytic activity dem-
onstrable in vitro [19]. 
Precise regulatory mechanisms have been evolved to allow 
the 26S proteasomes to exist in the cytosol and nucleus of the 
eukaryotes without general proteolytic damages to the cell 
[20]. A number of such regulatory proteins, including the ac-
tivators [21-23] and the inhibitors [24-26] of the proteolytic 
function, have been identified. PA700 [22] is a 19S ATPase 
complex containing multiple members of a nucleotide-binding 
protein family [27-30] and associating with the 20S protea-
some in an ATP-dependent manner to form the 26S protea-
some. On the other hand, an ATP-independent activator pro-
tein, PA28 from bovine [21] or an US regulator from human 
[31], was identified. The purified PA28 is a complex of two 
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Fig. 1. SDS-PAGE and immunoblottings of the 20S proteasomes isolated from T. brucei and rat blood cells. Proteasomes were purified from 
the procyclic form (lane 1) and bloodstream form (lane 2) of T. brucei and rat blood cells (lane 3) using a previously described procedure [39]. 
The resolved proteasome subunit protein bands in 12.5% acrylamide gels were either stained with silver (A) or transferred to PVDF membrane 
and immunostained with the polyclonal antibodies against 20S proteasome from procyclic T. brucei (B), bloodstream T. brucei (C), and humans 
(D). 
subunits, PA28a and PA28(3, which share about 50% amino 
acid sequence identity [32,33]. They form a complex with the 
20S proteasome and enhance its peptidase activities both in 
vitro [21,34,35] and in vivo [36,37]. The stoichiometry of this 
complex formation has recently been demonstrated as a het-
erohexamer composed of three PA28a and three PA28p sub-
units in an alternating order [36]. But its true biological func-
tion in vivo remains unknown. Recent evidence suggests a 
possible role for PA28 in regulating the quantity and quality 
of in vivo peptide production by the 20S proteasome for anti-
gen presentation [13,38]. The in vivo interaction between the 
activated 20S and the 26S proteasomes to orchestrate the 
selective proteolysis remains to be explored. 
Trypanosoma brucei is the causative agent of African sleep-
ing sickness. This protozoan parasite can propagate as the 
procyclic form in the tsetse fly or differentiate into the blood-
stream form in the mammalian host. Recently, we have iden-
tified and characterized the 20S proteasome from T. brucei 
[39]. Trypanosome 20S proteasomes exhibit striking morpho-
logical similarities to the rat blood cell 20S proteasome under 
electron microscopy. But the antibodies against the human 
20S proteasome showed no crossreactivity to the trypanosome 
20S proteasome. Furthermore, substrate specificity analysis 
showed that the trypanosome 20S proteasome has an unusu-
ally high trypsin-like activity, rather than chymotrypsin-like 
activity, which is the typical peptidase activity of rat 20S pro-
teasome [39]. Leupeptin, an aldehyde known to inhibit the 
weak trypsin-like activity of mammalian proteasomes [40], 
demonstrated a potent inhibitory effect on the peptidase ac-
tivity of purified trypanosome 20S proteasomes, further sug-
gesting a possible functional dissimilarity between trypano-
some and mammalian proteasomes. In fact, while the ODC-
antizyme complex is subjected to rapid degradations by 26S 
proteasomes in mammalian cells, co-expression of mouse 
ODC and rat antizyme in T. brucei did not lead to rapid 
degradation of the former [41], suggesting that the trypanoso-
mal proteasome may have evolved a catalytic property differ-
ent from their mammalian host. The phenomenon became 
even more puzzling in our previous study when only a 20S 
proteasome, but not a 26S proteasome, could be purified from 
T. brucei in the presence of ATP and glycerol [39], which have 
been shown to stabilize the 26S proteasomes from rabbit re-
ticulocytes, human kidney, rabbit skeletal muscle, Drosophila 
embryo, Xenopus oocytes, spinach leaves, and Saccharomyces 
cerevisiae [16]. In our numerous attempts to identify a 26S 
proteasome in T. brucei, the established purification procedure 
for 26S proteasomes was modified in different ways which led 
to the identification and characterization of another form of 
the 20S proteasome, which we called the activated 20S pro-
teasome because it exhibited much higher peptidase activities 
than the original 20S proteasome. The activated 20S protea-
some was identified and purified from both procyclic and 
bloodstream forms of T. brucei. It contains an extra protein 
of 26 kDa to the 20S proteasome. This 26 kDa protein can be 
separated from the proteasomes by DE52 column chromatog-
raphy and re-introduced into the purified 20S proteasome to 
reconstitute the activated 20S proteasome. The presence of 
such an activated 20S proteasome rather than a homolog of 
the 26S proteasome in trypanosome suggests that the 26 kDa 
protein may play an important role in regulating the protea-
some-mediated protein degradations in trypanosomes. 
2. Materials and methods 
2.1. Materials 
Trypanosoma brucei strain 427 procyclic form and bloodstream 
form cells were prepared as described previously [39]. Rat blood cells 
were collected from Sprague-Dawley rats. Glycerol was from Fisher 
Scientific. The fluorogenic peptides LLVY-MAC, AAF-MAC, IIW-
MAC, AFK-MAC, PFR-MAC, and GGR-MAC were purchased 
from Sigma, and YVAD-MAC from Peptide Internationals. Immobi-
lon-P PVDF membrane was from Millipore. Molecular weight stand-
ards for SDS-PAGE were a group of broad range protein markers 
from New England Biolab. Prestained low molecular weight protein 
markers were from BioRad. The substrate for ELISA, o-phenyldi-
amine, was from Sigma. The rabbit antiserum against human 20S 
proteasome was a gift from Dr. Martin Rechsteiner (University of 
Utah). Horse radish peroxidase (HRP)-conjugated donkey antiserum 
against rabbit IgG was from Amersham. 
2.2. Electrophoresis and immunoblotting 
Native polyacrylamide gel electrophoresis (native PAGE) and SDS-
PAGE were in 4.5% and 15% acrylamide, respectively, as described 
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Fig. 2. Fractionation of proteasomes by glycerol gradient centrifugations. Crude proteasome fractions from rat blood cells (A), procyclic forms 
(B) and bloodstream forms (C) of T. brucei were further purified by glycerol gradient centrifugations (see Section 2). 10 ul of each collected 
fractions from the centrifugation was subjected to native PAGE and gel overlay assay using a mixture of LLVY-MCA, PFR-MCA and GGR-
MCA as substrate. Numbers indicate the collected fractions (starting from the bottom of the tube) containing 50% (lanes 1-3), 40% (lanes 4-6) 
and 35% (lane 7) glycerol. Panels on the left are the gel overlay assay results, and those on the right are the same gels stained with Coomassie 
blue. The protein bands labelled with an arrowhead (upper band) and 20S (lower band) in panels B and C were traced with a densitometer 
and the peak areas covered by the upper bands ( ) and lower bands ( ) of panel B ( • ) and panel C (o) were plotted against the frac-
tion numbers (D). 
[39], Immunoblottings were performed by a previously described pro-
cedure [39]. Densitometry scanning was performed with an LKB laser 
scanner. 
2.3. Peptidase assay and gel overlay assay 
Peptidase assays and gel overlay assays were performed as de-
scribed previously [39]. The substrate used for the gel overlay assay 
was GGR-MCA unless otherwise specified. 
2.4. Preparation of antibodies against the 20S proteasome from 
trypanosomes 
The 20S proteasomes were isolated from the bloodstream forms 
and the procyclic forms of T. brucei, respectively, as previously re-
ported [39]. The purified 20S proteasomes were further fractionated in 
native gel electrophoresis and the activity bands were excised from the 
gel for immunization of rabbit. Immunization and serum collection 
were performed by Animal Pharm Service, Inc., California. Specificity 
of the antisera was analyzed in immunoblottings of the purified 20S 
proteasomes resolved in SDS-PAGE. 
2.5. Isolation of proteasomes from T. brucei 
The entire purification procedure was modified from the procedures 
of Hua et al. [39] and carried out at 4°C unless otherwise noted. 
Briefly, 2 ml of freshly prepared cell pellets of T. brucei were washed 
twice with 10 ml phosphate-buffered saline containing 10% glucose, 
and used immediately for purification. Cell pellets were resuspended in 
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Fig. 3. Identification of the activated 20S proteasome from T. brucei. A: A crude proteasome fraction from procyclic form T. brucei cells was 
applied to a 1 X 30 cm column of Superose 6. Each collected fraction was analyzed by native PAGE and gel overlay assay to identify the frac-
tions containing proteasomes, pooled (horizontal bar) and concentrated with an Amicon 30 concentrator. Arrows indicate the positions of mo-
lecular weight markers including dextran blue (2000 kDa), ferritin (440 kDa) and bovine serum albumin (67 kDa). B: The pooled and concen-
trated sample from A was analyzed in native PAGE stained with Coomassie blue (panel a); the gel overlay assay (panel b); and 
immunoblotting stained with the rabbit antiserum (panel c) to the purified 20S proteasomes from procyclic T. brucei. The arrowhead points to 
the activated 20S proteasome. The numbers 1, 2, 3 and 4 on the left designate the protein bands visualized by Coomassie blue staining. 
two volumes of buffer A (10 mM Tris-HCl pH 7.4, 25 mM KC1, 10 
mM NaCl, 1 mM MgCl2, 0.2 mM EDTA, 1 mM DTT and 2 mM 
ATP) containing 1 mM TLCK, 1 mM PMSF, and 20% glycerol. Cells 
were lysed by sonication until no apparent intact cells were observed 
under the light microscope. The lysate was cleared by centrifugation 
at 80000Xg for 60 min. Proteasome fractions were recovered from 
the supernatant by ultracentrifugation at lOOOOOXg for 60 min in a 
Beckman TLA100 [39]. Protein pellets were resuspended in 200 JJ.1 
buffer B (buffer A containing 1 mM TLCK, 1 mM PMSF, and 5% 
glycerol), and the insoluble material was removed by centrifugation at 
80000Xg for 30 min. The cleared supernatant was referred to as the 
crude proteasome fraction. 
The crude proteasome fraction (200 uf) was overlaid on top of 
a stepwise glycerol gradient (1.8 ml) containing 225 ul of 15, 20, 25, 
30, 35, 40, 45, and 50% glycerol in buffer B, and centrifuged at 38 000 
rpm with a TLS55 rotor (Beckman) for 16 h. Fractions (100 uf) 
were collected from the bottom of the tube. Peptidase activities 
in these fractions were immediately fractionated in native PAGE 
and stained by gel overlay assay followed by Coomassie blue stain-
ing. 
2.6. Isolation of the activated 20S proteasome from T. brucei 
The crude proteasome fraction was prepared from 5-7 ml trypano-
some cell pellets in the absence of ATP, Millipore filtered and frac-
tionated by gel filtration chromatography on a Superose 6 column 
equilibrated with buffer A at a flow rate of 0.2 ml/min. Fractions of 
0.5 ml were collected, and the content of each fraction was analyzed in 
native PAGE and stained for peptidase activity followed by Coomas-
sie blue stain. Fractions containing both the original 20S proteasome 
and the activated 20S proteasome were pooled with the glycerol con-
centration brought down to 5% and concentrated with Centricon 30 
to a final volume of 200 uj. The sample was further fractionated in 
glycerol gradient centrifugation as described above, and the purified 
fractions were stored at —70°C. 
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Fig. 4. Fractionation of proteasomes from the procyclic form of T. brucei in the absence of added ATP. The experimental protocols were iden-
tical to those detailed in Fig. 2 except that no ATP was added throughout the purification. 
2.7. Separation of the 26 kDa protein from T. brucei proteasomes and 
its reconstitution with the 20S proteasome 
Proteasome fractions containing both the 20S proteasome and the 
activated 20S proteasome were purified from the bloodstream form of 
T. brucei as described previously. The proteasome fraction (140 itg) 
was passed through a mini-column (BioRad) containing 200 ul DE52 
equilibrated with buffer C (buffer A containing 20% glycerol without 
ATP). The column was then washed with 10 ml buffer C and step 
eluted with 300 ul elution buffer C containing 0.10, 0.15, 0.20, 0.30 
and 0.40 M KC1. 10 ul of each of the eluted fractions was analyzed by 
SDS-PAGE followed by silver staining. The fractions eluted from 0.10 
and 0.15 M KC1 and containing the 26 kDa protein were pooled. The 
KC1 concentration was brought down to 0.05 M by dilution with 
buffer C and concentrated to 50 ul using a Centriprep 30 (Amicon). 
The total protein was measured with the Bradford method and the 
purity of 26 kDa protein was analyzed in a densitometer. 
The 20S proteasome from the bloodstream form was purified as 
described previously [39]. 4 ul (1252 ng) of this fraction was incubated 
with 20 ul 26 kDa protein (58.5 ng) at 37°C for 20 min. The sample 
was then analyzed in native PAGE. The peptidase activity was meas-
ured by gel overlay assay using a mixture of fluorogenic peptides 
containing GGR-MCA, LLVY-MCA and PFR-MCA. The protein 
bands were revealed by silver staining. 
2.8. Measurements of specific peptidase activity 
The original 20S proteasomes and the activated 20S proteasomes 
were separated from each other by a preparative native PAGE. The 
two activity bands were excised after gel overlay assay and incubated 
in an equal volume of buffer A for 1 h with occasional agitation. 
Supernatant was then used in the peptidase assays on different indi-
vidual fluorogenic peptides and proteasome concentrations were de-
termined by enzyme linked immunosorbent assays (ELISA) (see be-
low). The specific peptidase activity of the purified proteasome was 
expressed as nmol of MCA generated by 1 mg protein within 1 min. 
Protein concentrations of the proteasome samples were estimated with 
the Bradford assay (BioRad). For those samples with protein concen-
trations too low to be detected by the Bradford method, the method 
of ELISA was used, carried out at 37°C unless otherwise specified. 
Briefly, proteasome samples were two-fold serially diluted in 0.1 M 
carbonate-bicarbonate buffer, pH 9.6, and added to each well (100 ul) 
in duplicate. A serially diluted 20S proteasome standard was included 
in each plate and processed in parallel with the sample. The plate was 
incubated for 1 h and non-specific bindings were blocked with phos-
phate buffered saline (PBS) containing 1% bovine serum albumin, pH 
7.4. The plate was washed twice with PBS containing 0.05% Tween-20 
(PBS-Tween). 100 ul rabbit antiserum against trypanosomal 20S pro-
teasome (1:1000) was introduced and incubated for another hour. 
After washing thrice with PBS-Tween, 100 ul HRP-conjugated don-
key anti-rabbit antiserum (1:5000) was added and incubated for 30 
min. The plate was washed five times with PBS-Tween, and 100 ul 
freshly prepared 0.034% (w/v) substrate solution with 2% hydrogen 
peroxide in 0.2 M citrate-phosphate buffer pH 5.0 was added. After a 
30 min incubation, the reaction was stopped by 100 ul 2 M sulfuric 
acid and the absorbance at 490 nm was measured using a Dynatech 
Microplate Reader with a reference filter at 600 nm. Concentrations 
of the proteasome samples were determined by referring their optical 
density to the standard curve. 
3. Results 
3.1. Antibodies to T. brucei 20S proteasomes do not cross-react 
with the 20S proteasome from rat blood cells 
A rabbit antiserum to the purified 20S proteasome from 
bloodstream form T. brucei was tested in immunoblott ings 
and shown to crossreact with proteasomes from the two forms 
of T. brucei but not with that from rat blood cells (Fig. 1C). 
Similarly, antibodies to the 20S proteasome from procyclic 
form T. brucei recognized the proteasomes from both forms 
of T. brucei but not that from rat blood cells (Fig. IB). As 
shown previously [39], a rabbit antiserum to the human 20S 
proteasome crossreacted with the rat blood cell 20S protea-
some but failed to react with most of the subunit proteins in 
the 20S proteasomes from the bloodstream and the procyclic 
forms of T. brucei, except for a doublet band in the 24 k D a 
region (Fig. ID) . These data indicate that the structures of 
subunit proteins in the 20S proteasome from T. brucei are 
mostly distinct from those in the rat 20S proteasome. The 
Table 1 
Comparisons of specific peptidase activities (nmol/mg/min) between the 20S and the activated 20S proteasomes purified from the bloodstream 
and procyclic forms of T. brucei 
Substrate 
LLVY-MCA 
AAF-MCA 
IIW-MCA 
AFK-MCA 
PFR-MCA 
GGR-MCA 
YVAD-MCA 
Blood stream form 
Proteasomes 
20S 
69.2 
19.6 
20.2 
1.3 
34.2 
158.0 
0.8 
Activated 20S 
217.8 
104.5 
211.3 
104.5 
120.8 
292.7 
88.9 
Activation factor 
3.1 
5.3 
10.5 
78.7 
3.5 
1.9 
112.7 
Procyclic 
Proteasoi 
20S 
6.2 
2.3 
4.8 
0.6 
43.3 
147.9 
0.4 
form 
nes 
Activated 20S 
91.0 
59.0 
72.7 
64.3 
90.3 
210.7 
69.7 
Activation factor 
14.6 
25.4 
15.0 
106.9 
2.1 
1.4 
156.6 
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Fig. 5. SDS-PAGE analysis of the individual protein bands identified in the native PAGE of purified proteasomes from the procychc form of 
T. brucei. The individual protein bands 1, 2, 3 and 4, identified in Fig. 3B panel a, were each excised from the native polyacrylamide gel and 
subjected to SDS-PAGE in lanes 1-4 (panel A). Lane 5 contains a sample of the crude proteasome fraction from the procyclic form T. brucei 
cells as described in Fig. 3. The silver-stained lanes 2 and 3 were each analyzed in densitometer tracings with the results presented in panel B. 
proteasomes from the two forms of T. brucei differ very little 
(see Fig. 1B,C) except that the antibodies against bloodstream 
T. brucei proteasomes react a little more strongly with the 
subunit protein(s) in the 34 kDa region (Fig. 1C). There 
was weaker immunostaining of protein bands in the 24 kDa 
region by either preparation of antibodies, which may be at-
tributed to varying immunogenicities of individual proteaso-
mal subunit proteins and different immune responses in in-
dividual rabbits rather than a proteasomal subunit protein 
profile change between the two forms of T. brucei. 
3.2. No 26S proteasome can be identified or isolated from 
T. brucei 
When the proteasomes were isolated in the presence of 
added ATP (2 mM) in our previous efforts, both 20S and 
26S proteasomes were obtained from the rat blood cells 
whereas only the 20S proteasomes were obtained from T. 
brucei [39]. A similar result was reproduced in the present 
isolation of proteasomes from rat blood cells. The 26S pro-
teasome was clearly identified in the 50% glycerol fraction of 
the density gradient (Fig. 2A, lanes 1 and 2), well separated 
from the 20S proteasome sedimented in the 40% glycerol frac-
tion (Fig. 2A, lanes 3, 4 and 5). However, when both forms of 
T. brucei were brought through this same purification proce-
dure, no peptidase activity band corresponding to the 26S 
proteasome was detectable in the 50%> glycerol fraction after 
the ultracentrifugation (Fig. 2B,C, lanes 1 and 2). Although a 
major protein band was observed in the 26S proteasome re-
gion in Fig. 2B,C, lanes l^t, it contained only protein of 56-
66 kDa but not the 20S proteasome subunit proteins in sub-
sequent SDS-PAGE analysis (see Fig. 5A, lane 1). There are 
two possible explanations for this negative outcome: (a) T. 
brucei 26S proteasome becomes dissociated during this purifi-
cation; (b) T. brucei does not have a 26S proteasome (see 
Section 4). 
Upon a closer examination of Fig. 2B,C, however, we no-
ticed the presence of two peptidase activity bands in the T. 
brucei sample from the 40% glycerol fraction (Fig. 2B,C, lanes 
3-5). The lower band corresponds to the 20S proteasome 
purified from both forms of T. brucei in the previous study 
[39]. The upper band appears to consist of less protein than 
the corresponding 20S band but much higher peptidase activ-
ity. An analysis of the intensity of each Coomassie blue 
stained protein band versus the location of each collected 
fraction in the glycerol gradient centrifugation (Fig. 2D) in-
dicates that the upper band has moved a little farther toward 
the bottom of the gradient than the 20S proteasome, suggest-
ing a somewhat higher molecular weight than the T. brucei 
20S proteasome. Similar results were reproduced in each of 
the 6 independent purification experiments performed subse-
quently, suggesting that this small discrepancy in molecular 
weights is real (data not shown). Comparisons between the 
individual integrated protein peak areas in Fig. 2D show that 
the ratio between the upper and lower bands is 0.51:1 in the 
procyclic form (Fig. 2B) and 0.67:1 in the bloodstream form 
of T. brucei (Fig. 2C). An analysis of the individual activity 
bands by densitometer tracings indicates that the ratio be-
tween the upper and lower bands is 12:1 in the procyclic 
form (Fig. 2B) and 73:1 in the bloodstream form of T. brucei 
(Fig. 2C). The upper band in the bloodstream form thus ap-
pears to have 4.6 times higher specific peptidase activity than 
that in the procyclic form on a combination of substrates 
LLVY-MCA, PFR-MCA and GGR-MCA. 
3.3. Identification of an activated 20S proteasome species in 
T. brucei 
The crude proteasome fractions prepared from both the 
bloodstream and the procyclic forms of T. brucei (see Section 
2) were each fractionated through a Superose 6 (Pharmacia) 
gel filtration column, and the fractions containing a broad 
protein peak in the estimated range of 440 kDa were pooled 
(Fig. 3A). This pooled sample demonstrated two major pro-
tein bands in native PAGE (Fig. 3B, lane a) corresponding to 
the upper protein band and the 20S proteasome band in Fig. 
2B,C. Gel overlay assay for peptidase activity confirmed the 
previous observation that the upper protein band possesses a 
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Fig. 6. SDS-PAGE (A) and immunoblottings (B) of the purified ac-
tivated 20S proteasome (lane 1) and the purified 20S proteasome 
(lane 2) from the procyclic forms of T. brucei. The experimental de-
tails are the same as described in Fig. 1. The antibodies used were 
from a 1:1 mixture of rabbit antisera against the purified 20S pro-
teasomes from both forms of T. brucei. 
much higher peptidase activity than the 20S proteasome (Fig. 
3B, lane b). Immunoblotting of the same native PAGE gel 
with the rabbit antiserum to the 20S proteasome from procy-
clic T. brucei had both protein bands stained by the antibodies 
(Fig. 3B, lane c). This upper protein band must thus contain 
some or all of the subunit proteins from T. brucei 20S pro-
teasome. 
The upper protein band and the 20S proteasome band were 
each separately excised from the native gel and eluted into 
buffer solution. They were then each assayed on a variety of 
fluorogenic peptide substrates for construction of the profiles 
of their peptidase activities. The results presented in Table 1 
demonstrate that the peptidase activity profiles of the 20S 
proteasomes from both forms of T. brucei are very similar 
to each other and essentially the same as reported from our 
previous studies [39]. Thus, they have very high peptidase 
activity on Suc-GGR-MCA but rather low activities on Suc-
YVAD-MCA and Suc-AFK-MCA. The specific activities be-
tween the two extremes differ by more than two orders of 
magnitude (Table 1). When the eluted upper protein band 
was examined in the same assays, it demonstrated higher pep-
tidase activities on all the substrates and achieved a similarly 
high specific activity range of 64.3 to 292.7 nmol/mg/min on 
all the fluorogenic peptides tested (Table 1). These assays were 
repeated on 4 different batches of proteasomes purified from 
both forms of T. brucei. The absolute values of the specific 
peptidase activities in the purified samples varied from batch 
to batch, depending on the quality of each purified sample. 
But activities in the upper protein band remain uniformly high 
on all substrates and, consequently, the factor of activation 
between the upper protein band and the corresponding 20S 
proteasome band on each substrate stays relatively unchanged 
among different batches of proteasomes (data not shown). We 
thus designated the upper protein band the 'activated 20S 
proteasome'. 
3.4. Characterization of the activated 20S proteasome from 
T. brucei 
In our subsequent studies, ATP was eliminated from the 
purification procedure (see Section 2). The result turned out 
to be the same, i.e. both the 20S proteasome and the activated 
20S proteasome were isolated from T. brucei in a similar ratio 
as previously indicated (Fig. 4). The stability of the activated 
20S proteasome is thus apparently independent of ATP. A 
recent review of our previous efforts in purifying proteasomes 
from T. brucei [39] indicated that the activated 20S protea-
some was never detected either in the presence or in the ab-
sence of 2 mM ATP. There was, however, one extra step in 
the previous purification procedure that was eliminated from 
the present procedure, the proteasomes were used to be ad-
sorbed to a DEAE-cellulose column (DE52) and eluted in a 
gradient of 50-300 mM KC1 in buffer A containing 2 mM 
ATP [39]. When a mixture of the 20S proteasome and the 
activated 20S proteasome from our present study were eluted 
through the DE52 column in 300 mM KC1, the activated 20S 
proteasome could not be recovered, thus suggesting an insta-
bility of the activated 20S proteasome at relatively high ionic 
strengths. 
3.5. Identification and characterization of a 26 kDa protein 
from the activated 20S proteasome 
The independence from ATP and the sensitivity toward 
high salts have been among the characteristics of the bovine 
PA28 activator protein-20S proteasome complex [21]. This 
complex consists of a 20S proteasome associated with a hex-
amer of the 28 kDa activator protein PA28 at either end of 
the cylindrical structure [36]. In order to verify whether the 
activated 20S proteasome from T. brucei represents a similar 
complex, the individual protein bands 1, 2, 3 and 4 from the 
native PAGE of T. brucei proteasomes were each excised from 
the gel (Fig. 3B, lane a) and subjected to SDS-PAGE (Fig. 
5A). The results show that the only detectable difference be-
tween the purified activated 20S proteasome and the purified 
20S proteasome (compare lanes 2 and 3) is that the former 
consists of an extra major protein band with an estimated 
molecular mass of 26 kDa. Densitometer tracing of the two 
lanes (Nos. 2 and 3) indicated an approximate ratio of 12:1 
between the 26 kDa protein band and one of the well-sepa-
rated 32 kDa subunit protein band (Fig. 5B). Although the 
result may suggest an association of about 12 molecules of the 
26 kDa protein with each T. brucei 20S proteasome, the var-
iation in silver staining efficiency of different proteins abro-
gates this conclusion in the absence of other supporting data. 
We then tried to verify whether the 26 kDa protein could be a 
degradation product from one of the 20S proteasome subunit 
proteins as exemplified in the case of proteasomes from hu-
man erythrocyte [40] (see Section 4). Rabbit antisera against 
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Fig. 7. Separation of the 26 kDa protein from the proteasomes from T. brucei bloodstream forms and reconstitution of the activated 20S pro-
teasome. A: SDS-PAGE analysis of the fractions collected from a DE52 column chromatography of a crude proteasome sample; lane 1, the 
crude proteasome sample; lane 2-6, fractions collected from 0.10 M, 0.15 M, 0.20 M, 0.30 M and 0.40 M KCl, respectively. B: Native PAGE 
analysis of the incubated mixture of the 26 kDa protein and the 20S proteasome. Panel a, the silver stains. Lane 1, the 20S proteasome from 
T. brucei bloodstream forms; lane 2, the incubated mixture. The arrowhead in panel A indicates the band of 26 kDa protein; the arrow in 
panel B points to the activated 20S proteasome. 
the purified 20S proteasomes from both forms of T. brucei 
were mixed in an equal ratio and tested on immunoblottings 
of the gels from SDS-PAGE of the activated 20S proteasome 
from T. brucei. The results, shown in Fig. 6, suggest that the 
26 kDa protein is not a degradation product of the 28-34 kDa 
subunit proteins stained prominently by the antibodies. 
We then separated the 26 kDa protein from the total pro-
teasome fraction isolated from the bloodstream form of T. 
brucei by DE52 column chromatography. The fractions eluted 
from the column were analyzed in SDS-PAGE (Fig. 7A). The 
results demonstrate that the 26 kDa protein was eluted exclu-
sively at 0.10 M and 0.15 M KCl (Fig. 7A, lanes 2 and 3, 
respectively) without any indication of contamination from 
the 20S proteasome. The latter was eluted at 0.20 and 0.30 
M KCl (Fig. 7A, lanes 4 and 5, respectively) which exhibit a 
typical profile of the subunit proteins of T. brucei 20S protea-
some without the presence of the 26 kDa protein band. 
The isolated 26 kDa protein sample was desalted and com-
bined with the 20S proteasome purified from T. brucei blood-
stream forms at an approximate molar ratio of 1.4:1. The 
mixture was incubated at 37°C for 20 min and analyzed in 
native PAGE for protein and peptidase activity (Fig. 7B). The 
results indicated the emergence of a faint protein band with a 
slower mobility than the 20S proteasome from the reconstitu-
tion experiment (Fig. 7B, panel b, lane 2). Although the slow-
er-moving band has much less protein than the 20S protea-
some band, they share roughly equivalent levels of peptidase 
activities (Fig. 7B, panel a, lane 2), thus suggesting that the 
former is most likely the activated 20S proteasome. 
The positive outcome from the reconstitution experiment 
have provided a strong evidence that the 26 kDa protein is 
a homolog of bovine PA28 capable of forming a complex with 
the 20S proteasome in trypanosome to bring the latter to an 
activated state. We thus designated the 26 kDa protein 'PA26' 
in the subsequent discussion. 
4. Discussion 
In our present investigations, an 'activated' 20S proteasome 
species was identified and isolated from both bloodstream and 
procyclic forms of T. brucei. The activated 20S proteasome is 
apparently a complex between our originally identified 20S 
proteasome [39] and a 26 kDa protein PA26. Although fur-
ther analysis of PA26 has not yet been carried out to see if it 
represents more than a single molecular species, the independ-
ence from ATP, the instability in passing through a DE52 
column and the lack of immune crossreactivity between 
PA26, the other 20S proteasome subunit proteins exhibited 
by this activated 20S proteasome and the outcome from the 
reconstitution study suggest that it may be similar to the 
structure of bovine PA28-20S proteasome complex [21]. 
The specific peptidase activities in the activated 20S protea-
some are uniformly higher on all the fluorogenic peptides 
tested thus far and attain similarly high levels, regardless of 
whether the proteasomes are of bloodstream form or procyclic 
form origin. The lack of substrate specificity has negated the 
highly unusual substrate specificities originally observed with 
the regular 20S proteasome, i.e. very high trypsin-like activity, 
low chymotrypsin-like activity and extremely low peptidylglu-
tamyl-peptide hydrolase activity [39]. Similar observations on 
the mammalian proteasomes indicated that binding of PA28 
or US regulator to the 20S proteasomes also markedly altered 
the profiles of substrate specificity of the latter [21]. With the 
non-discriminatory enhancements of peptidase activities on all 
peptides tested, it is anticipated that the profile of protein 
degradations in T. brucei will also change with the changing 
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ratios between the activated and the regular 20S proteasomes 
in this organism. Since T. brucei is known to lack vigorous 
transcriptional regulation of its gene expression [42], it will be 
interesting to raise the question whether a regulation of the 
ratio between the activated and the regular 20S proteasome in 
T. brucei plays a role in controlling gene expression and cel-
lular differentiation. The expression of PA28 and US regula-
tor in mammalian cells is induced by interferon y [32,43]. The 
latter is also found in our recent studies to induce a MAP 
kinase homolog in bloodstream T. brucei but not in the pro-
cyclic form of T. brucei [44]. It remains to be seen whether 
interferon y will also induce the PA26 in the bloodstream T. 
brucei and thus cause a changed profile of protein degrada-
tions from that of the procyclic form. The higher ratio of the 
activated vs. regular 20S proteasomes in the bloodstream form 
(Fig. 2D) tends to support this possibility, though many more 
experimental data will be needed to verify the biological func-
tion of the activated 20S proteasome inside T. brucei. 
Mammalian 20S proteasomes have been known to be acti-
vatable by heating to 55°C or incubating with basic polypep-
tides, SDS, guanidine HC1 or fatty acids; or even dialysis 
against water [45^17]. But we do not consider the activated 
20S proteasome from T. brucei a result from any of the con-
ditions mentioned above, because it was not exposed to any of 
them during its isolation. In the 20S proteasome purified from 
human erythrocytes, the proteolytic cleavage of a 32 kDa 
subunit protein to a 28 kDa protein was found correlated 
with the stimulation of proteasomal activity [48]. But the 
PA26 in the activated 20S proteasome from T. brucei did 
not crossreact with the antibodies to the purified proteasome, 
and is thus unlikely to be a degradative product from any one 
of the proteasomal subunit proteins (see Fig. 6). PA26 is more 
likely a homolog of bovine PA28 [21] and human US regu-
lator [31] because (a) its association with the 20S proteasome 
is not affected by ATP (see Figs. 2 and 4); (b) it can be 
separated from the 20S proteasome by elution through a 
DE52 column with 0.10 M to 0.15 M KC1 (see Fig. 7A); (c) 
it can be combined with the 20S proteasome to reconstitute 
the activated 20S proteasome (see Fig. 7B). It is thus reason-
able to conclude that the PA26-20S proteasome complex is the 
activated proteasome from T. brucei. 
The apparent absence of a 26S proteasome from T. brucei 
under the present experimental conditions is puzzling but we 
cannot conclude from the data that the 26S complex does not 
exist in this organism. Since two polyubiquitin homolog genes 
have been identified in T. brucei [49], and ubiquitinated pro-
teins have been detected in the high molecular weight regions 
of the T. brucei crude extracts [50], it has been assumed that 
the ubiquitin-proteasome protein degradation pathway is 
functional in T. brucei, thus suggesting that the 26S protea-
somes are present in this organism. However, recent studies 
have indicated that ubiquitination of IKB in T-lymphocytes 
activates its kinase activity instead of causing its degradation 
[51]. Ubiquitination is thus not always associated with the 
function of 26S proteasomes. Other recent studies in our lab-
oratory have also provided additional evidence indicating that 
two highly conserved protein components, S4 and S5a, in the 
19S complex of 26S proteasomes are missing from the crude 
extracts of T. brucei bloodstream and procyclic forms (unpub-
lished). S4 is one of the six putative ATPases found in the 26S 
proteasomes from yeast [52] and mammals [53]. There is 75% 
sequence identity between yeast and human S4, and the latter 
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can function in place of its yeast homolog within the 26S 
complex [52]. S5a binds specifically to multi-ubiquitinated pol-
ypeptide chains with high affinity [54], and homologous genes 
exist in many organisms [55]. Rabbit polyclonal antibodies to 
human S4 and S5a, obtained from Dr. Martin Rechsteiner of 
the University of Utah, were tested in immunoblottings of the 
T. brucei crude extracts, and no crossreacting protein band 
was detected in the extracts of either bloodstream or procyclic 
forms of T. brucei (data not shown). Although negative results 
are usually difficult to interpret, it is tempting to postulate 
that T. brucei may depend primarily on a balance between 
the 'activated' 20S proteasome and the regular 20S protea-
some for controlled protein degradations. 
The ubiquitins have been identified only among the eukar-
yotes [56]. The archaebacterium T. acidophilum possesses only 
simple 20S proteasomes [57], whereas Escherichia coli has the 
large multimeric proteases La [58] and Clp [59] both linking 
ATPase activity and proteolysis together without ubiquitin-
dependent protein degradation. A 26S proteasome species 
was identified in S. cerevisiae [60], but no PA28 homolog 
has been described in the yeast thus far. The mammals have 
apparently acquired both the 26S proteasome and the PA28-
20S proteasome complexes [61]. Now that our present data 
suggest that the trypanosomes may have only the 20S and the 
PA26-20S proteasomes, it may cast some new light on the 
course of evolution of proteasomes from the prokaryote to 
the eukaryote kingdom. 
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